The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormone

Journal of Physiology

Volumn 587, Issue 3, 2009, Pages 669-677

  Oldham, Jenny M ^a   Osepchook, Claire C ^b   Jeanplong, Ferenc ^a   Falconer, Shelley J ^a   Matthews, Kenneth G ^a   Conaglen, John V ^c   Gerrard, David F ^d   Smith, Heather K ^e   Wilkins, Richard J ^f   Bass, James J ^b   McMahon, Christopher D ^a  

^a RUAKURA RESEARCH CENTRE   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

^f UNIVERSITY OF WAIKATO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; MESSENGER RNA; MYOSTATIN; STAT5B PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; GENOTYPE; HORMONE RESPONSE; MALE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SEX DIFFERENCE; SKELETAL MUSCLE; GROWTH CURVE; HORMONAL REGULATION; HYPOPHYSECTOMY; MATURATION;

ANIMALS; BODY WEIGHT; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH HORMONE; MALE; MICE; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOSTATIN; SEX CHARACTERISTICS; STAT5 TRANSCRIPTION FACTOR;

EID: 59649095277     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2008.161521     Document Type: Article

References (43)

1. Brill KT, Weltman AL, Gentili A, Patrie JT, Fryburg DA, Hanks JB, Urban RJ & Veldhuis JD (2002). Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J Clin Endocrinol Metab 87, 5649-5657.
2. Choi HK & Waxman DJ (1999). Growth hormone, but not prolactin, maintains, low-level activation of STAT5a and STAT5b in female rat liver. Endocrinology 140, 5126-5135.
3. Choi HK & Waxman DJ (2000). Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: Developmental regulation and role in male-specific liver gene expression. Endocrinology 141, 3245-3255.
4. Davey HW, Wilkins RJ & Waxman DJ (1999). STAT5 signaling in sexually dimorphic gene expression and growth patterns. Am J Hum Genet 65, 959-965.
5. Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ & Grattan DR (2001). STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology 142, 3836-3841.
6. Dubreuil P, Pelletier G, Petitclerc D, Lapierre H, Couture Y, Brazeau P, Gaudreau P & Morisset J (1987). Influence of age and sex on basal secretion of growth hormone (GH) and on GH-induced release by porcine GH-releasing factor pGRF (1-29NH2) in growing pigs. Domest Anim Endocrinol 4, 299-307.
7. Eden S (1979). Age- and sex-related differences in episodic growth hormone secretion in the rat. Endocrinology 105, 555-560.
8. Forbes D, Jackman M, Bishop A, Thomas M, Kambadur R & Sharma M (2006). Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism. J Cell Physiol 206, 264-272.
9. Gabriel SM, Roncancio JR & Ruiz NS (1992). Growth hormone pulsatility and the endocrine milieu during sexual maturation in male and female rats. Neuroendocrinology 56, 619-625.
10. Gatford KL, Fletcher TP, Rao A, Egan AR, Hosking BJ & Clarke IJ (1997). GH, GH-releasing factor and somatostatin in the growing lamb: sex differences and mechanisms for sex differences. J Endocrinol 152, 19-27.
11. Gebert CA, Park SH & Waxman DJ (1999). Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation. Mol Endocrinol 13, 213-227.
12. Grobet L, Martin LJ, Poncelet D, Pirottin D, Brouwers B, Riquet J, Schoeberlein A, Dunner S, Menissier F, Massabanda J, Fries R, Hanset R & Georges M (1997). A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 17, 71-74.
13. Hayes VY, Urban RJ, Jiang J, Marcell TJ, Helgeson K & Mauras N (2001). Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: Metabolic and molecular effects. J Clin Endocrinol Metab 86, 2211-2219.
14. Ji S, Losinski RL, Cornelius SG, Frank GR, Willis GM, Gerrard DE, Depreux FF & Spurlock ME (1998). Myostatin expression in porcine tissues: Tissue specificity and developmental and postnatal regulation. Am J Physiol Regul Integr Comp Physiol 275, R1265-R1273.
15. Kambadur R, Sharma M, Smith TPL & Bass JJ (1997). Mutations in myostatin (GDF8) in double-muscle Belgian blue and Piedmontese cattle. Genome Res 7, 910-915.
16. Kirk S, Oldham J, Kambadur R, Sharma M, Dobbie P & Bass J (2000). Myostatin regulation during skeletal muscle regeneration. J Cellular Physiol 184, 356-363.
17. Klover P & Hennighausen L (2007). Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/b in muscle: A role for autocrine/paracrine insulin-like growth factor I. Endocrinology 148, 1489-1497.
18. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
19. Le Roith D, Bondy C, Yakar S, Liu J-L & Butler A (2001). The somatomedin hypothesis: 2001. Endocr Rev 22, 53-74.
20. Liu J-L & LeRoith D (1999). Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 140, 5178-5184.
21. Liu W, Thomas SG, Asa SL, Gonzalez-Cadavid N, Bhasin S & Ezzat S (2003). Myostatin is a skeletal muscle target of growth hormone anabolic action. J Clin Endocrinol Metab 88, 5490-5496.
22. Lundby C, Nordsborg N, Kusuhara K, Kristensen KM, Neufer PD & Pilegaard H (2005). Gene expression in human skeletal muscle: alternative normalization method and effect of repeated biopsies. Eur J Appl Physiol 95, 351-360.
23. Lupu F, Terwilliger JD, Lee K, Segre GV & Efstratiadis A (2001). Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229, 141-162.
24. McFarlane C, Langley B, Thomas M, Hennebry A, Plummer E, Nicholas G, McMahon C, Sharma M & Kambadur R (2005). Proteolytic processing of myostatin is auto-regulated during myogenesis. Dev Biol 283, 58-69.
25. MacLeod JN, Pampori NA & Shapiro BH (1991). Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J Endocrinol 131, 395-399.
26. McMahon CD, Popovic L, Jeanplong F, Oldham JM, Kirk SP, Osepchook CC, Wong KW, Sharma M, Kambadur R & Bass JJ (2003 a). Sexual dimorphism is associated with decreased expression of processed myostatin in males. Am J Physiol Endocrinol Metab 284, E377-E381.
27. McMahon CD, Wilkins RJ, Davey HW, Xie T, Jeanplong F, Oldham JM, Kirk SP, Osepchook CC, Sharma M, Kambadur R & Bass JJ (2003 b). Stat5b may mediate the post-translational decrease of mature myostatin peptide in male mice (Abstract). The Endocrine Society, 85th Annual Meeting, Philadelphia.
28. McPherron AC, Lawler AM & Lee S-J (1997). Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387, 83-90.
29. McPherron AC & Lee SJ (1997). Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A 94, 12457-12461.
30. Pincus SM, Gevers EF, Robinson IC, van den Berg G, Roelfsema F, Hartman ML & Veldhuis JD (1996). Females secrete growth hormone with more process irregularity than males in both humans and rats. Am J Physiol Endocrinol Metab 270, E107-E115.
31. Reisz-Porszasz S, Bhasin S, Artaza JN, Shen R, Sinha-Hikim I, Hogue A, Fielder TJ & Gonzalez-Cadavid NF (2003). Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab 285, E876-E888.
32. Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, Fowke PJ & Bass JJ (1999). Myostatin, a transforming growth factor-β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 180, 1-9.
33. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO & Ohlsson C (1999). Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 96, 7088-7092.
34. Sokal RR & Rohlf FJ (1995). Biometry: The Principles and Practice of Statistics in Biological Research, 3rd edn, pp. 1-887. W.H. Freeman, New York.
35. Tannenbaum GS, Choi HK, Gurd W & Waxman DJ (2001). Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity. Endocrinology 142, 4599-4606.
36. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J & Kambadur R (2000). Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275, 40235-40243.
37. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ & Davey HW (1997). Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A 94, 7239-7244.
38. Veldhuis JD & Bowers CY (2003). Human GH pulsatility: An ensemble property regulated by age and gender. J Endocrinol Invest 26, 799-813.
39. Xu BC, Wang X, Darus CJ & Kopchick JJ (1996). Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor. J Biol Chem 271, 19768-19773.
40. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B & LeRoith D (1999). Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A 96, 7324-7329.
41. Yamaguchi A, Fujikawa T, Tateoka M, Soya H, Sakuma K, Sugiura T, Morita I, Ikeda Y & Hirai T (2006). The expression of IGF-I and myostatin mRNAs in skeletal muscle of hypophysectomized and underfed rats during postnatal growth. Acta Physiol (Oxf) 186, 291-300.
42. Yang J, Ratovitski T, Brady JP, Solomon MB, Wells KD & Wall RJ (2001). Expression of myostatin pro domain results in muscular transgenic mice. Mol Reprod Dev 60, 351-361.
43. Zhu X, Topouzis S, Liang LF & Stotish RL (2004). Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 26, 262-272.